/

Investors / Australia / SYNthesis BioVentures

SYNthesis BioVentures

Venture capital · Australia · Asia Pacific

synthesisbioventures.com

SYNthesis BioVentures is a registered ESVCLP fund focused on early stage therapeutics, investing in projects from discovery through preclinical proof of concept and IND enabling studies. It invests in small molecule therapeutics, biologics, and cell and gene therapies for indications with significant unmet need, and integrates investees into the SYNthesis Group's management and R&D operations.

Invests inHealthcare & Biotech

In its own wordstherapeuticsbiotechsmall moleculesbiologicscell and gene therapydrug discovery

Your fit with SYNthesis BioVentures

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
6portfolio companies
0funding rounds on record
Seed to Growthstages it states
ESVCLP registered with capitallatest fund2024

SYNthesis BioVentures lists 6 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in Australia.

No funding round on record names SYNthesis BioVentures yet, so the figures come from its portfolio page.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
3Lines1

All co-investors

Investor profile

percentile among all firms
Portfolio size: 6 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 100% in its largest sectorReach: 1 countryPortfolio size8th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus100th pctReach19th pct
This firmMedian of all firms
Show as a table
SYNthesis BioVentures compared with all firms
MeasurePercentile of all firmsValue
Portfolio size8th6 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus100th100% in its largest sector
Reach19th1 country

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers6100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Compare SYNthesis BioVentures head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Funds

from public registers and its site
SYNthesis BioVentures I, LP2024 · ESVCLP registered with capital, business.gov.au

Portfolio

6 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Aculeus Therapeuticsaculeustx.com · AustraliaAculeus Therapeutics discovers and develops immune-modulatory small molecules to treat disease
Healthcare & Biotech
Portfolio page
Anaxis Pharmaanaxispharma.com
Portfolio page
Catalyst Therapeuticscatalysttx.com · AustraliaCatalyst Therapeutics is an investment and project management company that accelerates the transition from research to drug development.
Healthcare & Biotech
Portfolio page
Portara BioSciencesportarabio.com
Portfolio page
Qubigenqubigen.com · AustraliaQubigen deploys AI and quantum chemistry for autonomous drug discovery
Healthcare & Biotech
Portfolio page
Skin2Neuronskin2neuron.org · AustraliaSkin2Neuron develops regenerative medicine technology to treat neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease
Healthcare & Biotech
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of SYNthesis BioVentures, as last read
synthesisbioventures.com as VCinfo last read it
Site
synthesisbioventures.com
Last read
5 Nov 2026
Watching since
6 Nov 2026
Companies checked
6

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get SYNthesis BioVentures' profile as data

Pull SYNthesis BioVentures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/synthesisbioventures.com

# also
GET /v1/firms/synthesisbioventures.com/portfolio
GET /v1/firms/synthesisbioventures.com/coinvestors
GET /v1/firms/synthesisbioventures.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing